Gil Roth01.16.12
Almac has opened a new $4.5 million building at its Craigavon, UK headquarters from which staff will provide services to customers in more than 100 countries. Around 150 staff from Almac’s Clinical Services Business Unit have moved to the new 30,000-sq.-ft. building to consolidate the group.
Staff working in the pharmaceutical development unit’s new offices will co-ordinate and manage the processes involved in packaging and distribution of medicinal supplies for clinical studies "carried out as far afield as Argentina and Zimbabwe," according to a company statement.
Many of the staff are clinical project managers and project co-ordinators, while business development, marketing, human resources and information systems departments are also based in the new building.
Celine Bradley, global vice president of operations, commented, “This addition to Almac’s continuously expanding headquarters brings together staff who have been working from different facilities on site for the past few years. Almac’s project staff manage clinical studies all around the world, providing cutting-edge services that enhance the global clinical supply chain and contribute to the ethical goal of getting new treatments into the market faster."
Staff working in the pharmaceutical development unit’s new offices will co-ordinate and manage the processes involved in packaging and distribution of medicinal supplies for clinical studies "carried out as far afield as Argentina and Zimbabwe," according to a company statement.
Many of the staff are clinical project managers and project co-ordinators, while business development, marketing, human resources and information systems departments are also based in the new building.
Celine Bradley, global vice president of operations, commented, “This addition to Almac’s continuously expanding headquarters brings together staff who have been working from different facilities on site for the past few years. Almac’s project staff manage clinical studies all around the world, providing cutting-edge services that enhance the global clinical supply chain and contribute to the ethical goal of getting new treatments into the market faster."